Association of the Monocyte-to-High-Density Lipoprotein Cholesterol Ratio with Gastrointestinal Involvement of Immunoglobulin a Vasculitis

References

• Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65(1):1–11. doi:10.1002/art.37715
   PubMed Web of Science ®Google Scholar
• Nossent J, Raymond W, Keen H, Inderjeeth C, Preen DB. Hospitalisation rates and characteristics for adult and childhood immunoglobulin A vasculitis in Western Australia. Intern Med J. 2019;49(4):475–481. doi:10.1111/imj.14065
   Web of Science ®Google Scholar
• García-Porrúa C, Calviño MC, Llorca J, Couselo JM, González-Gay MA. Henoch-Schönlein purpura in children and adults: clinical differences in a defined population. Semin Arthritis Rheum. 2002;32(3):149–156. doi:10.1053/sarh.2002.33980
   PubMed Web of Science ®Google Scholar
• Kang Y, Park JS, Ha YJ, et al. Differences in clinical manifestations and outcomes between adult and child patients with Henoch-Schönlein purpura. J Korean Med Sci. 2014;29(2):198–203. doi:10.3346/jkms.2014.29.2.198
   PubMed Web of Science ®Google Scholar
• Sunderkötter CH, Zelger B, Chen KR, et al. Nomenclature of cutaneous vasculitis: dermatologic addendum to the 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheumatol. 2018;70(2):171–184. doi:10.1002/art.40375
   PubMed Web of Science ®Google Scholar
• Audemard-Verger A, Pillebout E, Amoura Z, et al. Gastrointestinal involvement in adult IgA vasculitis (Henoch-Schönlein purpura): updated picture from a French multicentre and retrospective series of 260 cases. Rheumatology. 2020;59(10):3050–3057. doi:10.1093/rheumatology/keaa104
   PubMed Web of Science ®Google Scholar
• Hočevar A, Tomšič M, Jurčić V, Perdan Pirkmajer K, Rotar Ž. Predicting gastrointestinal and renal involvement in adult IgA vasculitis. Arthritis Res Ther. 2019;21(1):302. doi:10.1186/s13075-019-2089-2
   Web of Science ®Google Scholar
• Berthelot L, Jamin A, Viglietti D, et al. Value of biomarkers for predicting immunoglobulin A vasculitis nephritis outcome in an adult prospective cohort. Nephrol Dial Transplant. 2018;33(9):1579–1590. doi:10.1093/ndt/gfx300
   Web of Science ®Google Scholar
• Nagy GR, Kemény L, Bata-Csörgő Z. Neutrophil-to-lymphocyte ratio: a biomarker for predicting systemic involvement in adult IgA vasculitis patients. J Eur Acad Dermatol Venereol. 2017;31(6):1033–1037. doi:10.1111/jdv.14176
   Web of Science ®Google Scholar
• Balta S. Endothelial dysfunction and inflammatory markers of vascular disease. Curr Vasc Pharmacol. 2021;19(3):243–249. doi:10.2174/18756212MTA1oOTYh3
   Web of Science ®Google Scholar
• Song Y, Huang X, Yu G, et al. Pathogenesis of IgA vasculitis: an up-to-date review. Front Immunol. 2021;12:771619. doi:10.3389/fimmu.2021.771619
   Web of Science ®Google Scholar
• Acikgoz N, Kurtoğlu E, Yagmur J, Kapicioglu Y, Cansel M, Ermis N. Elevated monocyte to high-density lipoprotein cholesterol ratio and endothelial dysfunction in Behçet disease. Angiology. 2018;69(1):65–70. doi:10.1177/0003319717704748
   PubMed Web of Science ®Google Scholar
• Omar T, Karakayalı M, Yesin M, Alaydın HC, Karabağ Y, Gümüşdağ A. Monocyte to high-density lipoprotein cholesterol ratio is associated with the presence of carotid artery disease in acute ischemic stroke. Biomark Med. 2021;15(7):489–495. doi:10.2217/bmm-2020-0705
   PubMed Web of Science ®Google Scholar
• Zhou Y, Wang L, Jia L, et al. The monocyte to high-density lipoprotein cholesterol ratio in the prediction for atherosclerosis: a retrospective study in adult Chinese Participants. Lipids. 2021;56(1):69–80. doi:10.1002/lipd.12276
   Web of Science ®Google Scholar
• Ozen S, Pistorio A, Iusan SM, et al. EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: ankara 2008. Part II: final classification criteria. Ann Rheum Dis. 2010;69(5):798–806. doi:10.1136/ard.2009.116657
   PubMed Web of Science ®Google Scholar
• Maronese CA, Zelin E, Avallone G, et al. Cutaneous vasculitis and vasculopathy in the era of COVID-19 pandemic. Front Med. 2022;9:996288. doi:10.3389/fmed.2022.996288
   Web of Science ®Google Scholar
• Xu S, Han S, Dai Y, Wang L, Zhang X, Ding Y. A review of the mechanism of vascular endothelial injury in immunoglobulin a vasculitis. Front Physiol. 2022;16(13):833954. doi:10.3389/fphys.2022.833954
   Google Scholar
• Ghattas A, Griffiths HR, Devitt A, Lip GY, Shantsila E. Monocytes in coronary artery disease and atherosclerosis: where are we now? J Am Coll Cardiol. 2013;62(17):1541–1551. doi:10.1016/j.jacc.2013.07.043
   PubMed Web of Science ®Google Scholar
• Combadière C, Potteaux S, Rodero M, et al. Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C (hi) and Ly6C (lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation. 2008;117(13):1649–1657. doi:10.1161/CIRCULATIONAHA.107.745091
   PubMed Web of Science ®Google Scholar
• Wu TT, Zheng YY, Chen Y, Yu ZX, Ma YT, Xie X. Monocyte to high-density lipoprotein cholesterol ratio as long-term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention. Lipids Health Dis. 2019;18(1):180. doi:10.1186/s12944-019-1116-2
   PubMed Web of Science ®Google Scholar
• Goswami B, Rajappa M, Singh B, Ray PC, Kumar S, Mallika V. Inflammation and dyslipidaemia: a possible interplay between established risk factors in North Indian males with coronary artery disease. Cardiovasc J Afr. 2010;21(2):103–108.
   PubMed Web of Science ®Google Scholar
• Ansell BJ, Navab M, Hama S, et al. Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment. Circulation. 2003;108(22):2751–2756. doi:10.1161/01.CIR.0000103624.14436.4B
   PubMed Web of Science ®Google Scholar
• Kuvin JT, Rämet ME, Patel AR, Pandian NG, Mendelsohn ME, Karas RH. A novel mechanism for the beneficial vascular effects of high-density lipoprotein cholesterol: enhanced vasorelaxation and increased endothelial nitric oxide synthase expression. Am Heart J. 2002;144(1):165–172. doi:10.1067/mhj.2002.123145
   PubMed Web of Science ®Google Scholar
• Karadağ ŞG, Çakmak F, Çil B, et al. The relevance of practical laboratory markers in predicting gastrointestinal and renal involvement in children with Henoch-Schönlein Purpura. Postgrad Med. 2021;133(3):272–277. doi:10.1080/00325481.2020.1807161
   PubMed Web of Science ®Google Scholar
• Ahn SS, Yoon T, Song JJ, Park YB, Lee SW. Serum albumin, prealbumin, and ischemia-modified albumin levels in patients with ANCA-associated vasculitis: a prospective cohort study. PLoS One. 2022;17(7):e0271055. doi:10.1371/journal.pone.0271055
   Google Scholar
• Jauhola O, Ronkainen J, Koskimies O, et al. Clinical course of extrarenal symptoms in Henoch-Schonlein purpura: a 6-month prospective study. Arch Dis Child. 2010;95(11):871–876. doi:10.1136/adc.2009.167874
   PubMed Web of Science ®Google Scholar